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Abstract
Reactive protein cysteine thiolates are instrumental in redox regulation. Oxidants, such as
hydrogen peroxide (H2O2), react with thiolates to form oxidative post-translational modifica-
tions, enabling physiological redox signaling. Cardiac disease and aging are associated
with oxidative stress which can impair redox signaling by altering essential cysteine thio-
lates. We previously found that cardiac-specific overexpression of catalase (Cat), an
enzyme that detoxifies excess H2O2, protected from oxidative stress and delayed cardiac
aging in mice. Using redox proteomics and systems biology, we sought to identify the cyste-
ines that could play a key role in cardiac disease and aging. With a ‘TandemMass Tag’
(TMT) labeling strategy and mass spectrometry, we investigated differential reversible cys-
teine oxidation in the cardiac proteome of wild type and Cat transgenic (Tg) mice. Revers-
ible cysteine oxidation was measured as thiol occupancy, the ratio of total available versus
reversibly oxidized cysteine thiols. Catalase overexpression globally decreased thiol occu-
pancy by1.3 fold in 82 proteins, including numerous mitochondrial and contractile pro-
teins. Systems biology analysis assigned the majority of proteins with differentially modified
thiols in Cat Tg mice to pathways of aging and cardiac disease, including cellular stress
response, proteostasis, and apoptosis. In addition, Cat Tg mice exhibited diminished pro-
tein glutathione adducts and decreased H2O2 production from mitochondrial complex I and
II, suggesting improved function of cardiac mitochondria. In conclusion, our data suggest
that catalase may alleviate cardiac disease and aging by moderating global protein cysteine
thiol oxidation.
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Introduction
Excessive oxidant formation is associated with cardiac disease and aging [1]. In an attempt to
ameliorate cardiac diseases and delay aging by decreasing oxidative stress, mouse models over-
expressing cellular antioxidant enzymes, including catalase, were created. Catalase detoxifies
the intracellular oxidant hydrogen peroxide (H2O2) [2]. We and others have previously shown
that cardiac-specific catalase overexpression in transgenic mice (Cat Tg) prevents oxidative
stress, preserves diastolic heart function and delays cardiac aging [3–5]. In addition, Cat Tg
mice are also protected from doxorubicin toxicity [6], ischemia-reperfusion injury [7,8],
inflammation [9], and overt heart failure [10].
H2O2 can have dual effects; acting at physiological levels as an essential signaling molecule
or in excess as a damaging oxidant [11]. Protein cysteine thiolates (Cys-S-), as compared to thi-
ols (Cys-SH), are chemically reactive and confer redox sensitivity. These thiolates or “redox
sensors” can react with H2O2 to form a labile sulfenic acid (S-OH) intermediate, which quickly
reacts with the abundant intracellular low-mass thiol glutathione (GSH). The resulting protein
GSH-adduct is a reversible oxidative protein modification that participates in cellular redox
signaling and regulates protein activity, interaction, localization, and stability [11,12]. Redox
signaling, however, becomes dysregulated or impaired when oxidants are generated in excess,
and this leads to oxidative stress and irreversible modifications as observed in cardiac disease
and aging.
We studied reversible protein cysteine thiol oxidation in heart lysates from adult wild type
and Cat Tg mice. Iodoacetyl ‘TandemMass Tags’ (iodoTMT) developed for multiplexed quan-
titative mass spectrometry were used in an approach similar to established biotin-switch assays
to label and analyze oxidation of protein cysteine thiols [13]. Using this labeling strategy in
combination with proteomics mass spectrometry, we determined the ratio of reversibly oxi-
dized cysteine thiols to total available cysteines—referred to as thiol occupancy—on a site-spe-
cific basis for wild type and Cat Tg mice. Significant differences in thiol occupancy for Cat Tg
andWT mice identify the most reactive and, therefore, potential functionally relevant cysteines
in proteins. We aimed to provide evidence that by overexpressing catalase, reactive cysteine
thiols are maintained in a functional state and protected from the irreversible oxidation
observed in cardiac disease and aging. Our results provide novel insights into catalase function
that, beyond ameliorating oxidative stress, may also influence protective cellular signaling
pathways.
Materials and Methods
Experimental animals and materials
Male and female FVB/N mice (N = 5 per group) with cardiac-specific catalase overexpression
and wild type controls were used. The protocol was approved by the Institutional Animal Care
and Use Committee at Boston University School of Medicine. Mice were euthanized at 10
months of age and hearts were perfused to remove blood proteins, excised, snap frozen, and
stored in liquid nitrogen or at -80°C. All materials were purchased from Thermo Fisher Scien-
tific (Waltham, MA, USA) unless otherwise specified.
Mitochondrial isolation
Heart mitochondria were isolated as we have described previously, with minor modifications
[14,15]. All steps were performed on ice. Briefly, tissues were rinsed in a buffer containing
100 mM KCl, 5 mM EGTA and 5 mMHEPES pH 7.4, and thereafter homogenized in 2 ml of
HES buffer (HEPES 5 mM, EDTA 1 mM, sucrose 0.25 M, pH 7.4 adjusted with KOH 1 M)
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using a Teflon-on-glass electric homogenizer. The homogenate was centrifuged at 500 × g for
10 min at 4°C. The supernatant was then centrifuged at 9000 × g for 15 min at 4°C and the
mitochondrial pellet was re-suspended in 100 μl of HES buffer with 0.3% of fatty acid-free
bovine serum albumin. Protein was quantified using the BCA assay (Pierce) and the value of
HES-BSA buffer alone was subtracted.
H2O2 production in isolated mitochondria
Mitochondrial H2O2 production in isolated cardiac mitochondria was measured using the
Amplex Ultra Red-Horseradish peroxidase method (Invitrogen) as we described previously,
with minor modifications [15]. This assay is based on the Horseradish peroxidase (2 units/ml)
H2O2-dependent oxidation of non-fluorescent Amplex Ultra Red (50 μM) to fluorescent resor-
ufin red. In short, 10 μg mitochondria were diluted in 50 μl reaction buffer (125 mM KCl,
10 mMHEPES, 5 mMMgCl2, 2 mM K2HPO4, pH 7.44) to determine complex I- (pyruvate/
malate, 5 mM) or complex II- (succinate, 5 mM; with and without inhibitor, rotenone 2 μM)
driven H2O2 production. Mitochondrial H2O2 production was measured after the addition of
50 μl of reaction buffer containing horseradish peroxidase and Amplex Ultra Red. Fluorescence
was followed at an excitation wavelength of 545 nm and an emission wavelength of 590 nm for
20 min. The slope of the increase in fluorescence is converted to the rate of H2O2 production
with a standard curve. All of the assays were performed at 25°C. The results are reported as
pmoles/min/mg protein.
ATP production in isolated mitochondria
ATP synthesis rates in isolated heart mitochondria were determined using the luciferin/lucifer-
ase based ATP Bioluminescence Assay Kit CLS II (Roche) as we have previously described,
with minor modifications [15]. In short, 10 μg of heart mitochondria were suspended in 75 μl
buffer A (125 mM KCl, 10 mMHEPES, 5 mMMgCl2 and 2 mM K2HPO4, pH7.44) to deter-
mine complex I- (pyruvate/ malate, 5 mM final) or complex II- (succinate, 5 mM final) driven
ATP synthesis. Following standard practice, succinate-driven ATP generation was measured in
the presence of complex I inhibitor rotenone (2 μM) to avoid the reverse electron transfer effect
[16]. Measurements with substrates were repeated in the presence of oligomycin to determine
the rates of non-mitochondrial ATP production. The background of the assay was determined
with mitochondria alone. The measurements for all samples were started simultaneously by
adding 75 μl of luciferin/luciferase buffer containing 1 mM ADP (0.5 mM final). The initial
slope of the increase in ATP-supported luciferase chemiluminescence was used to determine
the rate of ATP production after subtraction of the background and non-mitochondrial values.
Using an ATP standard provided in the kit, the slopes were converted to nmoles/min/mg
protein.
Oxygen consumption rate in isolated mitochondria
Oxygen consumption rates were monitored using a Seahorse XF24 oxygen flux analyzer, as
previously described by our group [14]. Isolated mitochondria were loaded in a 24-well Sea-
horse plate on ice (5–12.5 μg per well) and 500 μl of ice-cold mitochondrial assay solution
(MAS: 70 mM sucrose, 220 mMmannitol, 5 mM KH2PO4, 5 mMMgCl2, 2 mMHEPES, 1 mM
EGTA, 0.3% BSA fatty acid-free, pH 7.4) were added on top. The 4 sequential injection ports
of the Seahorse cartridge contained the following: Port A- 50 μl of 10X substrate (complex I:
50 mM pyruvate and 50 mMmalate; complex II: 50 mM succinate and 20 μM rotenone in
MAS) and 2.5 mM ADP, Port B- 55 μl of 20 μM oligomycin, Port C- 60 μl of 40 μM FCCP,
Port D- 65 μl of 40 μM antimycin A. State III was determined after port A injection, state IV
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after port B, and uncoupled after port C. Antimycin A was used as a control because it blocks
the electron transport chain to minimize mitochondrial oxygen consumption. The results are
reported as ρmol oxygen/min/μg protein.
Immunoblotting
Hearts were lysed in RIPA buffer (50mM Tis-HCl, pH 7.2, 0.15 M NaCl, 1.0 mM EDTA, 0.1%
SDS, 1.0% Triton X-100, 1.0% sodium deoxycholate). Tissue lysates were separated on non-
reducing SDS-polyacrylamide gels and transferred to polyvinylidene fluoride membranes
(Immobilon, Millipore), blocked in 5% nonfat milk, and incubated overnight with the anti-
GSH antibody (Virogen, 101-A). Subsequently, blots were incubated with IR dye-conjugated
secondary antibodies and visualized using the LI-COR Odyssey system. Band intensities were
measured using ImageJ, and values were normalized to GAPDH as a loading control.
Homogenization and protein extraction from heart tissue for mass
spectrometry analysis
The left heart ventricle was divided into two pieces; homogenization and extraction of individ-
ual pieces were carried out in lysis buffer containing 50 mM Tris pH 7.4, 150 mMNaCl
0.5 mM diethylene triamine pentaacetic acid (DTPA) (Sigma, St. Louis, MO) and protease
inhibitor cocktail (Roche Applied Science, Indianapolis, IN) (1 tablet/10 ml of lysis buffer) sup-
plemented with either 10 mM iodoacetamide (Sigma) to block free thiols or 1 mM tris(2-car-
boxyethyl)phosphine (TCEP, Thermo Fisher Scientific) to completely reduce all reducible
thiols. LVs were homogenized for two cycles of 54 sec in a gentleMACS Dissociator (MACS
Miltenyl Biotec, Cologne, Germany). Mass spectrometry compatible RapiGest SF surfactant
(0.1%, v/v, Waters, Milford, MA) was subsequently introduced into the lysis mixture to avoid
foaming during homogenization. Lysates were rotated for 2 h at 4°C, aliquotted, and frozen at
-80°C. The protein concentration for each sample was determined using the colorimetric Bio-
Rad detergent-compatible protein assay (BioRad, Hercules, CA) and by Imperial staining
(Thermo Fisher Scientific) of sodium dodecyl sulfate-polyacrylamide gels (SDS-PAGE).
iodoTMT-labelling and enrichment
One hundred μg of each protein lysate was used to label the reversibly oxidized thiols or total
available (all reducible) thiols, from either control or Cat Tg LV homogenates. Then 7-kDa
MWCO Zeba spin columns (Pierce, Thermo Scientific) equilibrated with Tris-buffered saline
(TBS: 25mM Tris and 0.15 M NaCl, pH 7.2–7.5) containing 5% acetonitrile (ACN) and 0.005%
ProteaseMAX (Promega, Madison, WI) were used to remove excess IAM from blocked sam-
ples before 45 min of reduction with TCEP at 37 oC. Completely reduced samples were thawed
and passed through 7kDa MWCO Zeba columns pretreated with TCEP-containing buffer, and
incubated to maintain conditions similar to blocked samples. Next, each sample was tagged
with a different isobaric iodoacetyl TandemMass Tag™ (iodoTMT™) reagent (Thermo Scien-
tific) at 1 mM for 2 h at room temperature. Samples representing all four conditions were com-
bined, then precipitated with acetone containing 0.1% acetic acid at -20°C overnight. Protein
pellets were washed with ice-cold acetone, and then resuspended in 1x Tris supplemented with
0.05% ProteaseMAX and 5% ACN. Proteins were digested with trypsin (1:20 enzyme-to-pro-
tein ratio) overnight at 37°C. Immobilized anti-TMT resin was used to immunoprecipitate (IP)
TMT-tagged peptides at a 1 μg protein/1 μl resin ratio overnight at 4°C. Resin was washed
three times with TBS, three times with 4 M urea, and four times with water. The TMT-tagged
peptides were eluted with TMT-elution buffer (Thermo Scientific) and concentrated in a vac-
uum concentrator at 4°C. Peptides were dissolved in 0.1% formic acid (FA) in 2% ACN and
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desalted with C18 spin columns (NestGroup). Peptides were eluted from the C18 columns
twice with 0.1% FA in 60% ACN. Samples were then dried using a SpeedVac™ concentrator
(Savant, Thermo Fisher Scientific) and reconstituted in 2% ACN with 0.1% FA. Preliminary
MS analysis was performed with an UltrafleXtreme MALDI-TOF/TOF MS (Bruker Daltonics,
Billerica, MA) using 2,5-dihydroxybensoic acid matrix, followed by analysis with the Q Exac-
tive™mass spectrometer described below.
Liquid chromatography-tandemmass spectrometry (LC-MS/MS)
LC-MS/MS was performed on peptide samples using a nanoAcquity UPLC™ nano-capillary
high-performance LC system (Waters Corp., Milford, MA) coupled to a Q Exactive™ hybrid
quadrupole-Orbitrap mass spectrometer (Thermo Fisher Scientific, San Jose, CA) equipped
with a TriVersa NanoMate ion source (Advion, Ithaca, NY). Sample concentration and desalt-
ing were performed online using a nanoAcquity UPLC™ trapping column (180 μm x 20 mm,
packed with 5 μm, 100 Å Symmetry C18 material, Waters Corp.) at a flow rate of 15 μl/min for
1 min. Separation was accomplished on a nanoAcquity UPLC™ capillary column (150 μm x
100 mm, packed with 1.7 μm, 130 Å BEH C18 material, Waters Corp.). A linear gradient of A
and B buffers (buffer A: 1.5% ACN/ 0.1% FA; buffer B: 98.5% ACN/ 0.1% FA) from 3% to 55%
buffer B over 120 min was used at a flow rate of 0.5 μl/min to elute peptides into the mass spec-
trometer. Columns were washed and re-equilibrated between LC-MS/MS experiments. Elec-
trospray ionization was carried out at 1.65 kV using the NanoMate, with the Q Exactive heated
transfer capillary set to 250°C. Mass spectra were acquired in the positive-ion mode over the
rangem/z 400–2000 at a resolution of 70,000 (fwhm atm/z 400), target AGC values of 1E6,
and maximum individual fill times of 200 ms. Mass accuracy after internal calibration was
within 1 ppm. MS/MS spectra were acquired at a resolution of 17,500 (fwhm atm/z 100), target
AGC values of 1E6, and isolation window of 3.0m/z, using higher-energy collisional dissocia-
tion (HCD) with 30% MS/MS collision energies (NCE) and nitrogen as the collision gas. Maxi-
mum individual fill time was set as 60 ms for the 10 most abundant, multiply-charged species
in each MS spectrum with signal intensities of> 3.3E5. MS/MS spectra were acquired over an
m/z range that depended on each precursor ion. Dynamic exclusion was set such that MS/MS
for each species was excluded for 2 sec post-acquisition. All spectra were recorded in profile
mode for further processing and analysis.
Data analysis
MS and MS/MS data analyses were carried out using Proteome Discoverer (PD) 1.4 (Thermo
Fisher Scientific). For Protein/peptide identification, the MS/MS spectra were searched against
the UniProtKB mouse protein database (20130107/83589 sequence entries) using the Sequest
HT search engine. The search was conducted with the following constraints: full tryptic pep-
tides with maximum four missed cleavage sites, precursor mass tolerance 10 ppm, and frag-
ment ion mass error 0.02 Da. IodoTMT6plex-labeled (C), di- and tri-oxidized (C),
carbamidomethyl (C), deamidation (NQ), and oxidation (M) were specified as dynamic modi-
fications. False discovery rate (FDR) was determined through decoy database search using Per-
colator node for peptide-spectrum-match (PSM) validation. Peptides assignment with
FDR<1% were indicated as highly confident and selected for further analysis.
For relative quantification of TMT-labeled cysteines, reporter ions were specified with the
integration tolerance of 20 ppm using most confident centroid method. Thermo lot-specific
reporter ion correction factors were applied for “quan value” determination. Protein GO anno-
tations and subcellular locations were derived from open source software STRAP (Cardiovas-
cular Proteomics Center, Boston University School of Medicine, Boston, MA) [17,18]. Peptide
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events without iodoTMT modification or without matched protein were excluded. For each
MS/MS spectrum used for quantification, PD used the intensity of each reporter ion to calcu-
late the following ratios between biological samples: 1) changes in total available cysteines and
2) changes in reversibly oxidized cysteine thiols. Only the median ratio was reported as the
change for the assigned peptide. Thiol occupancy caused by reversible oxidation was calculated
as the ratio of reversibly oxidized thiol to the total available thiols for the same peptide. These
values were then compared between mice. TMT-tagged peptides having less than 35% coeffi-
cients of variation (CVs) among measured replicate mice, both for their change in total avail-
able cysteine and reversibly oxidized cysteines, were selected for further analysis. Fold changes
between samples were expressed as log2 value of the ratios for all quantifiable peptides. The
proteins exhibiting changes in reversible thiol oxidation (cutoff1.3-fold change is common
threshold for gene chip and RT-qPCR analysis) were analyzed for functional relevance using
Ingenuity™ Pathway Analysis (IPA) (IPA™, QIAGEN Redwood City, www.qiagen.com/
ingenuity). Direct and indirect relationship data derived from all wild type and mutant cells
and tissue from mouse, rat, and human were included. Endogenous chemicals were also
included in the canonical pathway analysis.
Results and Discussion
Detection of reversible cysteine oxidation with TMT switch and mass
spectrometry
Using our previously published iodoTMT switch assay and mass spectrometry [13] (S1 Fig),
reversible protein cysteine thiol oxidation and total available cysteines were measured in left
ventricles from wild type and Cat Tg mice (N = 5). In summary, 2125 TMT-tagged peptides
were identified (S1 Table), which originated from 1017 proteins localizing to various subcellu-
lar compartments, including mitochondria (18%), cytoplasm (13%), nucleus (13%), plasma
membrane (8%), cytoskeleton (6%) and peroxisome/microbodies (1%) (Fig 1).
Global changes in protein cysteine thiol oxidation associated with
catalase overexpression
The global effects of catalase overexpression on total available (Fig 2A) and reversibly oxidized
cysteine thiols (Fig 2B), as well as thiol occupancy (Fig 2C) was measured for 199 qualifying
peptides (S2 Fig) from 147 proteins, which are depicted in a log2 transformed frequency
Fig 1. Detection of reversible cysteine thiol oxidation with TMT switch andmass spectrometry.
Cellular compartment pie chart of 1017 proteins containing TMT-tagged cysteine thiols.
doi:10.1371/journal.pone.0144025.g001
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histogram. Reversible cysteine thiol oxidation was significantly decreased in Cat Tg mice (a
log2 transformed mean of -0.52 indicates a 1.4-fold decrease in Cat Tg vs. WT, Fig 2B). Calcu-
lating the ratio of reversibly oxidized to total available cysteine thiols enables quantification of
changes in thiol occupancy, and can be used to differentiate regulatory cysteines in adult Cat
Tg mice. The thiol occupancy (Fig 2C, a log2 transformed mean of -0.68 indicates a 1.6-fold
decrease) was significantly decreased in Cat Tg mice and paralleled that of reversible cysteine
thiol oxidation.
Because no experimental precautions were taken to preserve very labile and transient cyste-
ine modifications, including S-nitrosylation and S-sulfenylation [19,20], and owing to high
intracellular glutathione levels [21], we deem that most of the thiol modifications are either
protein GSH adducts or disulfides. However, the type of modification needs to be determined
in future studies, on a case-by-case basis.
Overall, 17 proteins with increased total available cysteine thiols, and 82 proteins with
decreased reversible cysteine thiol oxidation exhibited biologically significant changes in Cat
Tg vs. WT mice. These proteins are involved in various cellular pathways that protect from oxi-
dative and metabolic stress, protein misfolding and apoptosis. Proteins with a2-fold change
in thiol occupancy are summarized in S2 Table. Below, we speculate about and discuss the
potential functional significance of thiol modifications of some of these proteins in the context
of cardiac disease and aging.
Effects of overexpression on catalase itself and other antioxidant
systems
Wemeasured a 14-fold increase in total available cysteines for catalase (Cat, Q3UF58) from
Cat Tg mice, clearly indicating catalase overexpression and thus, validating our proteomics
approach. Moreover, the regulatory site of catalase activity (Cys376) [22], exhibited a 24.5-fold
decrease in thiol occupancy.
Catalase is highly efficient in detoxifying large quantities of H2O2 and preventing oxidative
stress. These properties could protect other cellular antioxidants from oxidation and improve
their effectiveness. Peroxiredoxins, which also decompose H2O2, are highly redox-sensitive
proteins susceptible to irreversible oxidation [23,24]. Cys96, one of the two redox-active
Fig 2. Global changes in cysteine oxidation associated with catalase overexpression. Log2 transformed reporter ion rations from Cat Tg vs. WT mice
were used to generate frequency histograms of TMT-tagged peptides. The ratios used are as follows: (A) changes in the total available cysteines; (B)
changes in the reversibly oxidized cysteine thiols; (C) changes in the thiol occupancy of reversible oxidation (dashed line indicates no change with log2
ratio = 0).
doi:10.1371/journal.pone.0144025.g002
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cysteines in peroxiredoxin 5, showed decreased cysteine thiol oxidation, which likely improves
its activity (Prdx5, Q9JHL8, 1.2-fold decrease in thiol occupancy in Cat Tg vs. WT).
The redox-sensitive substrate binding sites of carbonyl reductase 1, an NADPH-dependent
short chain dehydrogenase/reductase [25–27], also showed attenuated oxidation in Cat Tg
mice (Cbr1, P48758, 3.0-fold decrease in thiol occupancy of Cys226 and Cys227 in Cat Tg vs.
WT). Cbr1 has been linked to the detoxification of reactive aldehydes, such as the lipid peroxi-
dation product 4-hydroxynonenal, under conditions of oxidative stress. Moreover, Cbr1 regu-
lates intracellular nitrosoglutathione levels [28], an intracellular storage form of nitric oxide,
which would impact cardiovascular physiology if the observed decrease in oxidation protects
Cbr1 function.
Mitochondria
Dysfunctional mitochondria are now recognized as a factor contributing to disease and aging
[1,29]. Catalase overexpression improved mitochondrial function in adult mice and attenuated
cysteine thiol oxidation of various proteins involved in apoptosis and mitochondrial
metabolism.
Pyruvate dehydrogenase (Pdha1, P35486) is a mitochondrial matrix enzyme that catalyzes
oxidative decarboxylation of pyruvate, producing acetyl-CoA that directly feeds into the citric
acid cycle. The enzyme plays a fundamental role in cardiac metabolism and adaptation to hyp-
oxic conditions [30]. Our proteomics study identified three cysteine sites with decreases in
thiol occupancy (1.3-fold for Cys181; 6.8-fold for Cys218 and Cys222 in Cat Tg vs. WT), which
would fit with previous reports that found these sites can be S-nitrosylated in the myocardium
[31].
Mammalian multiple mitochondrial dysfunctions syndrome 2 protein (MMDS2; also
BolA3, E9Q705) belongs to the BolA-like protein family that has been postulated to act as a
reductase for mitochondrial glutaredoxin [32,33]. BolA3 is involved in the assembly of iron-
sulfur cluster-containing mitochondrial proteins [33,34] and lipoate synthesis, directly affect-
ing the function of pyruvate dehydrogenase. Fibroblasts deficient in BolA3 exhibit perturba-
tions in the citric acid cycle and mitochondrial electron transport chain. Thus BolA3 would
improve mitochondrial respiration and ATP synthesis in Cat Tg mice if the observed decrease
in thiol oxidation increases BolA3 activity (Cys47, 2.9-fold decrease in thiol occupancy, Cat Tg
vs. WT). In our recent publications [13,15], increased cysteine oxidation in iron-sulfur clusters
was associated with metabolic heart disease. Particularly, cysteines of the complex II iron-sulfur
cluster were oxidized [15], which may contribute to increased oxidant formation in cardiac
and age-related diseases.
Mitochondrial protein serine hydroxymethyltransferase 2 (SHMT2, Q3TFD0, Cys77,
1.4-fold decrease in thiol occupancy, Cat Tg vs. WT) is involved in ‘one-carbon’ and folate
metabolism [35]. These metabolites are essential for nucleotide biosynthesis, numerous meth-
ylation reactions and maintaining low homocysteine levels. Increased serum homocysteine is a
well-established cardiovascular risk factor and would promote endothelial dysfunction and
atherosclerosis if cysteine oxidation leads to enzymatic inhibition of SHMT2.
Voltage-dependent anion-selective channel proteins (VDAC) [36,37] facilitate passive
exchange of ions and transport of ATP, ADP, pyruvate, malate, and other metabolites [38,39].
In conjunction with proteins of the Bcl-2 family, VDACs form the permeability transition
pore. During oxidant-mediated apoptosis, the pore opens, facilitating the release of cytochrome
C and initiation of additional apoptotic cascades [40,41]. For VDAC1, two cysteines—Cys127
and Cys232—are essential for crosslinking high order oligomers upon apoptosis induction
[42]. Because, Cys232 is proposed to play a particular role in apoptosis [42], a decrease in
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reversible cysteine oxidation could indicate suppression of myocyte apoptosis (VDAC1,
Q3U6K8, Cys232, 2.1-fold decrease in thiol occupancy; VDAC2, G3UX26, 2.0-fold decreased
in thiol occupancy for Cys36, 2.8-fold for Cys65, and 23.6-fold for in Cys199 and Cys216, Cat
Tg vs. WT) [43]. Attenuating myocyte apoptosis by protecting key mediators from oxidation
may preserve the functional integrity of the myocardium.
Extracellular matrix and contractile proteins
Myocardial dysfunction may be caused by various factors including dysregulated calcium
homeostasis [4] or cross-links of intracellular filamentous and extracellular matrix proteins.
Both effects can lead to cardiac muscle stiffening and impairment of relaxation. Catalase over-
expression attenuated cysteine thiol oxidation in various cardiac proteins associated with the
contractile apparatus, e.g. titin isoform 2 (Ttn, A2ASS6-2, 2.3-fold decrease in thiol occupancy
of Cys23752 in the fibronectin type-III domain, Cat Tg vs. WT); cardiac-type myosin-binding
protein C (Mybpc3, Q3TF37, 2.5-fold of decrease in thiol occupancy Cys1040 and Cys1041 in
the Ig-like C2-type domain, Cat Tg vs. WT), and the positive regulator of actin filament poly-
merization actin-related protein 2/3 complex subunit 2 (Arpc2, Q4FZG5, 1.7-fold decrease in
thiol occupancy of Cys96 in Cat Tg vs. WT).
LIM domain-containing cysteine- and glycine-rich proteins (Csrp) are involved in develop-
ment, cell growth, differentiation [44], and organization of cardiac contractile elements. The
LIM domains serve as protein-binding interfaces to mediate subcellular protein localization
and function [45]. For example, the first LIM domain and Gly-rich region in Csrp1 is necessary
for bundling of actin filaments. Csrp3 is a positive regulator of myogenesis and plays a crucial
role in the organization of the Z-line that also functions as a mechanical stretch sensor. In the
hearts of Cat Tg mice, these proteins exhibited decreases in thiol occupancy. Thus cysteine oxi-
dation of Csrp proteins may cause structural changes and defects in stretch sensing, leading to
remodeling of the myocardium (Csrp1, P97315, 2-fold decrease in thiol occupancy for Cys 58;
Csrp3, P50462, 3-fold decrease in thiol occupancy for Cys79 and 1.4-fold for Cys168, Cat Tg
vs. WT).
The latent transforming growth factor ß–binding protein 4 (Ltbp4, Q8K4G1, 2.5-fold
decrease in thiol occupancy of Cys1033, Cys1045 and Cys1051, Cat Tg vs. WT) is another fac-
tor that could be involved in cardiac remodeling. Ltbp4 belongs to the LTBP/fibrillin-family of
extracellular matrix (ECM) proteins [46] and forms large latent complexes with transforming
growth factor-ß (TGF-ß) in the ECM. These complexes regulate cell growth and differentia-
tion, immune function, and ECM synthesis and degradation.
Effects of cysteine oxidation on protein networks. Pathway analysis (IPA, Ingenuity Sys-
tems) was performed with the 82 proteins exhibiting a decrease of1.3-fold in reversible thiol
oxidation in hearts of Cat Tg vs. WT mice. These proteins mainly participate in the “canonical
pathways” of mitochondrial dysfunction, acute phase response signaling, TCA cycle, and
NRF2-mediated oxidative stress response (S3 Table). Interestingly, most proteins with2-fold
decrease in reversible cysteine thiol oxidation were found in metabolic pathways of the mito-
chondria, suggesting that catalase overexpression may prevent or delay mitochondrial dysfunc-
tion in disease and aging. Prevention of damage and apoptosis could be essential to
maintaining tissue homeostasis and function, particularly in post-mitotic tissues such as the
myocardium which lack significant capacity for tissue regeneration.
Our pathway analysis illustrates that 66 proteins with altered cysteine thiol oxidation in Cat
Tg mice may be associated with catalase through 11 central protein ‘nodes’ (S3 Fig). Major
‘node’ proteins include the tumor suppressor p53 (Fig 3) and many involved in proteostasis i.e.
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amyloid precursor protein (APP), small ubiquitin-like modifier 4 (SUMO4) (Fig 4), and ubi-
quitin C (UbC) (Fig 5).
Tumor suppressor p53. The transcription factor and cell cycle regulator p53 is best
known for its role as a tumor suppressor [47]. As a key component in the cellular stress
response, p53 is activated by numerous signals, including genotoxic damage, oncogene activa-
tion, nutrient or oxygen deprivation, and oxidative stress [48]. Dampened stress response and
attenuation of p53-dependent apoptosis probably leads to improved cell survival and could
preserve tissue function [49]. In post-mitotic heart tissue, where tumor suppression is not a
major concern, p53 likely perpetuates the disease and aging processes.
Fig 3. Pathway analysis-predicted protein networks associated with tumor suppressor p53. Legend to network analysis: enzyme (diamond),
transmembrane receptor (vertical oval), transcriptional regulator (horizontal oval), phosphatase (triangle), transporter (trapezoid), kinase(triangle), growth
factor (square), and other (circle). Relationships: interaction (line), activation (arrow).
doi:10.1371/journal.pone.0144025.g003
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Pathway analysis indicated that p53 may function as a central node linking 21 proteins that
exhibited differential thiol oxidation in Cat Tg mice (Fig 3). These proteins include regulatory
subunits of serine/threonine-protein phosphatases that modulate oncogenic, insulin, and stress
signaling cascades (Ppp2a, P63330, 2.0-fold decrease in thiol occupancy of Cys266; Ppp5c,
F7BX26, 1.7-fold decrease in thiol occupancy of Cys76, Cat Tg vs. WT) [50,51]. Ppp2a targets
various phosphorylation sites of p53, regulating its stability and transcriptional activity [52,53].
Another highly expressed p53-regulated cardiac protein with differential cysteine thiol oxi-
dation is N-Myc downstream regulated gene 2 (Ndrg2, Q9QYG0-2, 1.7- and 1.4-fold decreased
thiol occupancy of Cys64 and Cys241, respectively, Cat Tg vs. WT) [54–56]. Ndrg2 is a Myc-
repressed gene that regulates cell growth [57], differentiation [54], neurodegeneration [58],
and the stress response to oxygen deprivation [59].
Protein turnover and proteostasis. Protein homeostasis, or proteostasis, plays an impor-
tant role in the pathogenesis of many diseases [60]. To counter adverse effects of oxidative
stress, cells attempt to repair oxidized proteins by induction of chaperones, or by rapidly
channeling damaged proteins into the ubiquitin-proteasome system (UPS) or autophagy for
Fig 4. Pathway analysis-predicted protein networks associated with amyloid precursor protein (APP) and small ubiquitin-like modifier SUMO4.
Legend to network analysis: enzyme (diamond), transmembrane receptor (vertical oval), transcriptional regulator (horizontal oval), phosphatase (triangle),
transporter (trapezoid), kinase(triangle), growth factor (square), and other (circle). Relationships: interaction (—), activation (arrow).
doi:10.1371/journal.pone.0144025.g004
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degradation [61,62]. The UPS, however, is the main protein degradation system in the heart,
degrading up to 90% of intracellular proteins [63]. Accumulation of oxidized and misfolded
proteins is a characteristic of cardiac disease and aging. Proteolysis-resistant proteins, referred
to as soluble oligomeric forms of amyloidogenic proteins, exhibit cellular toxicity and may
form large insoluble protein aggregates. Applying pathway analysis (Figs 4 and 5) indicated
various proteins associated with ubiquitin C, small ubiquitin-like modifier (SUMO) 4 or
Fig 5. Pathway analysis-predicted protein networks associated with ubiquitin c (Ubc). Legend to network analysis: enzyme (diamond),
transmembrane receptor (vertical oval), transcriptional regulator (horizontal oval), phosphatase (triangle), transporter (trapezoid), kinase(triangle), growth
factor (square), and other (circle). Relationships: interaction (line), activation (arrow).
doi:10.1371/journal.pone.0144025.g005
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amyloid precursor protein (APP). In addition, isoform-ß of heat shock protein (HSP) 105,
which could be involved in preventing aggregation of denatured proteins [64,65], was less oxi-
dized in Cat Tg mice (Hsph1, Q61699-2, 1.7-fold decrease in thiol occupancy of Cys167, Cat
Tg vs. WT), potentially increasing or at least preserving its ability to repair altered proteins.
Protein aggregates may also bind and deplete other functionally significant proteins, thus, pre-
venting formation of these aggregates is critical to attenuating cardiac disease and aging.
Functional effects of catalase overexpression on cardiac mitochondria in
Cat Tg mice
We previously reported that hearts of Cat Tg at 21 months of age were protected from an age-
dependent decline in diastolic function and oxidative stress [4]. However, young and middle-
aged wild type (WT) and Cat Tg mice revealed no apparent differences in cardiac diastolic
function [4]. Because mitochondria can be a major cellular oxidant source [1], we measured
mitochondrial oxygen consumption rates, ATP synthesis and H2O2 generation. Mitochondria
isolated from adult Cat Tg mouse left ventricles produced significantly less H2O2 from com-
plexes I and II (Fig 6A) and exhibited increased ATP synthesis rates when utilizing either com-
plex I or II substrates (Fig 6B), sans significant differences in oxygen consumption rates (S4
Fig). This suggests that catalase overexpression could improve mitochondrial function by
decreasing ROS generation while concomitantly increasing the efficiency of oxidative phos-
phorylation. Consistent with the decrease in mitochondrial-derived H2O2 in Cat Tg mice, pro-
tein GSH-adducts were globally diminished (Fig 7), suggesting that reversible cysteine
oxidation detected by MS may be predominantly GSH-adducts. Furthermore, these data show
that adult mice already exhibit significant changes in reversible protein cysteine thiol oxidation
prior to an age-dependent decline in cardiac function. Catalase found in heart tissue has only
about 2% of native specific activity exhibited by catalase in the liver. This may explain the
heart’s vulnerability to basal levels of oxidants and the protective effects exhibited by cardiac
catalase overexpression [66–68].
Conclusion
Our proteomics screen to detect and quantify reversible cysteine thiol oxidation in the myocar-
dium of adult Cat Tg mice identified various alterations that could be pertinent to cardiac dis-
ease and aging. Preserved cardiac diastolic function was apparent in the hearts of adult Cat Tg
mice, yet we found a significant decrease in global reversible cysteine thiol oxidation, especially
of mitochondrial proteins. Thus, we postulate that these changes in cysteine oxidation contrib-
ute to the protective effects eventually conferred by catalase overexpression in aged mice [10].
The oxidation status of major biological pathways involved in cardiac disease and aging was
affected by catalase overexpression, including cellular stress response, proteostasis, antioxidant
systems, apoptosis and myocardial contractile apparatus. We believe that this proteomics study
identified novel target proteins that could be important for myocardial aging. Future studies
are required, to confirm the functional significance of these protein targets.
Supporting Information
S1 Fig. Multiplexed quantitation of reversible cysteine oxidation in Cat Tg andWTmice.
(A) TMT-switch labeling strategy. To determine the total available (free and reducible) cyste-
ines, half of each left ventricle was completely reduced and labeled with iodoTMT; to label only
reversibly oxidized cysteines, all free cysteines were blocked by IAM during lysis of the other
half of the same left ventricles. Then those reversibly oxidized cysteines were reduced by TCEP
prior to iodoTMT labeling. Tagged samples were pooled, precipitated to remove excess tag and
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Fig 6. Cardiac mitochondrial H2O2 production and ATP synthesis rates in Cat Tgmice. (A) H2O2 production rates with a complex I substrate (5 mM
pyruvate + 5 mMmalate) and with a complex II substrate (5 mM succinate and inhibitor of reverse electron transport 2 μM rotenone); (B) Complex I (5 mM
pyruvate + 5mMmalate) and complex II (5 mM succinate + 2 μM rotenone) substrate-driven ATP synthesis rates. Data represents means ± SEM; N = 5–7; *
P<0.05.
doi:10.1371/journal.pone.0144025.g006
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detergent, and digested with trypsin. Immonopurified tagged peptides were analyzed using a
Thermo Q Exactive MS/MS instrument. (B) MS data analysis strategy. From acquired MS/MS
Fig 7. Protein-GSH adduct levels are decreased in catalase transgenic mice.Consistent with the decrease in H2O2 formation, protein GSH adducts
were decreased in catalase transgenic mouse hearts, as measured byWestern blotting analysis using an anti-GSH adduct antibody. GAPDH protein levels
in hearts were analyzed byWestern blot to ensure equal protein loading.
doi:10.1371/journal.pone.0144025.g007
Reversible Cysteine Oxidation in Cardiac Disease and Aging
PLOS ONE | DOI:10.1371/journal.pone.0144025 December 7, 2015 15 / 20
spectra, the thiol occupancy was calculated as the ratio between reporter ions used tag revers-
ibly oxidized cysteines and those used to tag total available cysteines. TMT-tagged peptide/pro-
tein identification and quantitation from qualified mass spectra was performed in Proteome
Discoverer 1.4. Proteins exhibiting changes in reversible cysteine oxidation were further stud-
ied for their roles in biological pathways and system biology.
(TIF)
S2 Fig. Validation of TMT-tagged peptides. (A) Peptide frequency histogram of the coeffi-
cient of variation (CV) for changes in total available cysteine thiols (●), reversibly oxidized cys-
teine thiols (□) and their occupancy (Δ). (B) Distribution of TMT-tagged peptides. A total of
2264 peptides with modifications were detected by LC-MS/MS analysis, of which 2125 peptides
(94%) contained TMT-labeled cysteine thiols. The recovery of TMT-tagged peptide was greatly
improved by removing unreacted TMT tag using protein precipitation prior to incubation with
the TMT antibody resin. In summary, 1711 peptides (76%) of the peptides were single-, 348
peptides (15%) double-, and 66 peptides (3%) triple-tagged with TMT. While peptides contain-
ing a single cysteine enable quantification on a site-specific basis, peptides with multiple tagged
cysteines only allow measuring average oxidation across all affected cysteines. (C) Overlap of
TMT-tagged peptides exhibiting changes in total available (in white, left) and reversibly oxi-
dized cysteines (in light grey, right) with CV35%. Quantitative proteome analysis requires
stepwise selection of qualifying MS data (see methods for details). In general, reporter ions for
total available cysteine thiols (m/z 127 or 129) were more abundant than those for reversibly
oxidized cysteine thiols (m/z 126 or 128), resulting in better MS quantification and lower data
variability as determined by the coefficient of variation (CV). By selecting a cutoff CV of35%
for all reporter ion ratios, adequate analytical precision was attained. A total of 658 peptides
with quantification values for total available cysteine thiols and 285 peptides with quantifica-
tion values for reversibly oxidized cysteine thiols qualified for further analysis. The union of
both data sets contained 199 overlapping peptides, of which 109 peptides from 82 proteins
exhibited1.3-fold change in reversible cysteine oxidation. These 82 proteins were submitted
for biological pathway analysis.
(TIF)
S3 Fig. IPA predicted multiple protein networks associated with oxidative changes caused
by catalase overexpression. The 11 ‘node’ proteins are highlighted in grey. Legend to network
analysis: enzyme (diamond), transmembrane receptor (vertical oval), transcriptional regulator
(horizontal oval), phosphatase (triangle), transporter (trapezoid), kinase (triangle), growth fac-
tor (square), and other (circle). Relationships: interaction (line), activation (arrow).
(TIF)
S4 Fig. Cardiac mitochondrial maximal and uncoupled oxygen consumption were similar
in both groups. (A) Maximal (State III) and uncoupled (oligomycin 2μM) (State IV) complex
I substrate-driven oxygen consumption rate; (B) Maximal (State III) and uncoupled (oligomy-
cin 2 μM) (State IV) complex II substrate-driven oxygen consumption rate. Data represents
means ± SEM; N = 4–6.
(TIF)
S1 Table. Complete list of proteins with a change in thiol oxidation in Cat Tg vs. WT.
Accession number, gene ID, sites of modification and peptide sequences were retrieved from
the Uniprot knowledgebase. Fold changes in Cat Tg vs. WT, were calculated from ratio of
reporter ions for changes in total available cysteine as (m/z 129)/(m/z 127), reversibly oxidized
cysteine thiols as (m/z 128)/(m/z 126) and the thiol occupancy as ((m/z 128)/ (m/z 126))/((m/z
129)/(m/z 127)). The thiol occupancy columns indicate percentage thiol occupancy, calculated
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as (m/z 126)/(m/z 127) for WT, and (m/z 128) /(m/z 129) for Cat Tg, together with The stan-
dard error mean (SEM) was calculated from N = 5 biological replicates.
(DOCX)
S2 Table. Proteins with a change in thiol occupancy by>2-fold in Cat Tg vs. WT mice.
Accession number, gene ID, sites of modification and peptide sequences were retrieved from
the Uniprot knowledgebase. Fold changes in Cat Tg vs. WT, were calculated from ratio of
reporter ions for changes in total available cysteine as (m/z 129)/(m/z 127), reversibly oxidized
cysteine thiols as (m/z 128)/(m/z 126) and the thiol occupancy as ((m/z 128)/ (m/z 126))/
((m/z 129)/(m/z 127)). The thiol occupancy columns indicate percentage thiol occupancy, cal-
culated as (m/z 126)/(m/z 127) for WT, and (m/z 128) /(m/z 129) for Cat Tg, together with
The standard error mean (SEM) was calculated from N = 5 biological replicates.
(DOCX)
S3 Table. Proteins involved in five canonical pathways predicted in IPA, with a change in
thiol occupancy by>1.3-fold in Cat Tg vs. WT. Accession number, gene ID, sites of modifi-
cation and peptide sequences were retrieved from the Uniprot knowledgebase. Fold changes in
Cat Tg vs. WT, were calculated from ratio of reporter ions for changes in total available cysteine
as (m/z 129)/(m/z 127), reversibly oxidized cysteine thiols as (m/z 128)/(m/z 126) and the thiol
occupancy as ((m/z 128)/ (m/z 126))/((m/z 129)/(m/z 127)). The thiol occupancy columns
indicate percentage thiol occupancy, calculated as (m/z 126)/(m/z 127) for WT, and (m/z 128)
/(m/z 129) for Cat Tg, together with The standard error mean (SEM) was calculated from
N = 5 biological replicates.
(DOCX)
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